Published in Arch Klin Exp Dermatol on July 30, 1965
Degradation of human epidermal keratin by fish pepsin. Arch Dermatol Res (1988) 1.00
A simple assay for determining keratin and collagen degradation in vitro. Arch Dermatol Res (1988) 0.94
Investigative studies of the dermatitis caused by the larva of the brown-tail moth, Euproctis chrysorrhoea l. (Lepidoptera, Lymantriidae). III. Chemical analysis of skin reactive substances. Arch Dermatol Res (1977) 0.80
Degradation of human epidermal keratin by cod trypsin and extracts of fish intestines. Arch Dermatol Res (1989) 0.76
[Influencing the effect of epicutaneously applied trypsin by means of a trypsin inhibitor and dermatologic pretreatment of the human skin in vivo]. Arch Klin Exp Dermatol (1970) 0.75
Observations upon thermal burns: the influence of moderate temperature burns upon a proteinase of skin. J Physiol (1945) 7.34
Mechanical separation of the epidermis from the corium. J Invest Dermatol (1952) 3.07
[Histochemical and morphological studies of normal and pathological skin]. Arch Klin Exp Dermatol (1954) 2.84
A histochemical study on polysaccharides in normal and diseased skin. J Invest Dermatol (1950) 1.97
Epidermal protease. J Invest Dermatol (1953) 1.64
Human melanogenesis; cytology and histology of pigment cells (melanodendrocytes). AMA Arch Derm Syphilol (1952) 1.42
The nature of cantharidin acantholysis. J Invest Dermatol (1959) 1.33
The role of proteolytic enzymes in the production of pruritus in man. J Invest Dermatol (1955) 1.30
Whole mounts for the study of skin and its appendages. J Invest Dermatol (1954) 1.18
[Blister formation in skin layers; enzymatic aspects]. Arch Klin Exp Dermatol (1957) 1.13
[Demonstration of catheptic endopeptidase in normal human skin and in dermatoses]. Arch Klin Exp Dermatol (1959) 1.10
[On the mechanism of blister formation. I. Demonstration of the proteolytic activity of blister content]. Dermatologica (1959) 1.01
Further observations on the proteolytic enzymes in rat skin. Biochem J (1948) 1.00
Epidermal separation with purified trypsin. J Invest Dermatol (1958) 1.00
Distribution of tonofibrils and intercellular bridges by disulfide-splitting agents. J Invest Dermatol (1956) 0.99
[The histogenesis of skin blisters with comparative consideration in dermatoses and in experiment]. Arch Klin Exp Dermatol (1954) 0.99
[The mechanism of blister formation of the human skin]. Arch Klin Exp Dermatol (1955) 0.99
Biochemical changes in thermally-injured cutaneous tissue, susceptibility to proteolytic enzymes, and extractability of collagen. Proc Soc Exp Biol Med (1953) 0.94
[Value of determination of serum transaminases & lactic acid dehydrogenase in liver diseases]. Dtsch Med Wochenschr (1957) 0.94
Experiments on blister formation. I. Experiments with proteolytic enzymes and hyaluronidases. Dermatologica (1959) 0.91
Mechanisms of blister formation. AMA Arch Derm (1957) 0.91
[Additional histochemical studies of the homogenous part of the subepidermal border strip of the normal human skin]. Arch Klin Exp Dermatol (1955) 0.90
[Effect of hyaluronidase and heparin on experimental skin vesicle]. Arch Dermatol Syph (1953) 0.90
Experiments on blister formation. IV. The action of cantharidin. Dermatologica (1961) 0.89
Enzymatic vesication in vivo. I. Effects of papain in human skin. J Invest Dermatol (1960) 0.87
Microanatomical and histochemical observations on the dermal-epidermal junction. AMA Arch Derm (1958) 0.85
A method for the separation of the epidermis from the dermis. J Invest Dermatol (1950) 0.84
[Suitability of the plant protease bromelain for substitution therapy in digestive disorders]. Arzneimittelforschung (1965) 0.81
Disruption of epithelial cells by heat and specific chemical agents. J Invest Dermatol (1956) 0.80
Pruritus and proteolytic enzymes. AMA Arch Derm (1958) 0.78
Proteolytic activity in dermatoses: preliminary observations on inflammation and pruritus. J Invest Dermatol (1957) 0.78
Experiments on blister formation. III. Chemical induction of subepidermal blisters. Dermatologica (1961) 0.78
[Experimental epidermolysis of the skin as a pharmacological test method]. Hautarzt (1953) 0.78
Enzymatic cytolysis of epithelium by filtrates from patients with ulcerative colitis. J Invest Dermatol (1953) 0.78
Negative Haemoccult test in malignant and premalignant lesions of the colon. Validation of the Haemoccult test with total colonoscopy. Endoscopy (1989) 2.10
[Chronic recurrent subileus due to Strongyloides stercoralis infection under immunosuppressive therapy]. Dtsch Med Wochenschr (1996) 2.04
Human papilloma virus 5-DNA in a carcinoma of an epidermodysplasia verruciformis patient infected with various human papillomavirus types. Cancer Res (1983) 1.95
Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64
Partial nephrectomy and chronic renal failure: the 'mature' rat model. Contrib Nephrol (1988) 1.41
[Photometrical determination of enzyme activities in living epidermal cells]. Arch Klin Exp Dermatol (1971) 1.39
Zinc protoporphyrin in anemia of chronic disorders. Blood (1993) 1.21
Washing erythrocytes to remove interferents in measurements of zinc protoporphyrin by front-face hematofluorometry. Clin Chem (1992) 1.17
[The skin as absorptive organ from the pharmacokinetic viewpoint]. Arzneimittelforschung (1972) 1.09
Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1989) 1.07
Treponema pallidum in early syphilitic lesions in humans during high-dosage penicillin therapy. An electron microscopical study. Arch Dermatol Res (1976) 1.03
Thermographic analysis of skin test reaction using AGA thermovision. Arch Dermatol Res (1980) 1.03
Gastric mucosal dysplasia: what is its clinical significance? Front Gastrointest Res (1979) 0.99
[Significance of triglyceride splitting by C. acnes in acne vulgaris (author's transl)]. Arch Dermatol Forsch (1973) 0.97
Identification of the nusB gene product of Escherichia coli. Mol Gen Genet (1981) 0.96
[Inhibition of dermographism in human skin after topical application of caffeine]. Arch Dermatol Forsch (1972) 0.96
Ultrastructural detection of Haemophilus ducreyi in biopsies of chancroid. Arch Dermatol Res (1978) 0.94
Effects of septic shock on renal function in humans. Ann Surg (1967) 0.92
[Gastric mucosal dysplasias: what is their clinical significance (author's transl)]. Dtsch Med Wochenschr (1975) 0.92
Cannulation of subclavian vein for hemodialysis using Seldinger's technique. Trans Am Soc Artif Intern Organs (1978) 0.90
Absolute concentrations of an antimycotic agent, econazole, in the human skin after local application. Arzneimittelforschung (1976) 0.89
The quantitative distribution of percutaneously applied caffeine in the human skin. Arch Dermatol Res (1979) 0.88
[Penetration of a non-steroidal anti-inflammatory drug into human skin in vitro and in vivo. Tissue concentrations and flow rates of p-butoxyphenylacetohydroxamic acid (author's transl)]. Arzneimittelforschung (1978) 0.87
Glutamine auxotrophs of Bacillus subtilis that overproduce glutamine synthetase antigen have altered conserved amino acids in or near the active site. J Bacteriol (1989) 0.87
[Vitamin A acid in hyperkeratoses, epithelial tumors and acne]. Dtsch Med Wochenschr (1971) 0.87
[Distribution and inhibition of human esterolytic dermoproteinases]. Arch Klin Exp Dermatol (1969) 0.86
A rapid method for measuring drug enrichment in epidermis. Arch Dermatol Res (1980) 0.86
Acute renal failure after 5/6 nephrectomy: histological and functional changes. Contrib Nephrol (1988) 0.85
[Shuntless hemodialysis by puncturing the subcutaneously fixed superficial femoral artery]. Klin Wochenschr (1969) 0.85
Low-protein diet supplemented by keto acids in chronic renal failure: a prospective controlled study. Kidney Int Suppl (1983) 0.85
Quantitative determination of percutaneous absorption of radiolabeled drugs in vitro and in vivo by human skin. Curr Probl Dermatol (1978) 0.84
Influence of intentional femoral component flexion in navigated TKA on gap balance and sagittal anatomy. Knee Surg Sports Traumatol Arthrosc (2013) 0.84
[The pathophysiology of blistering (author's transl)]. Dermatologica (1980) 0.83
[Ligament instability in total knee arthroplasty--causal analysis]. Orthopade (2007) 0.82
[Clinical experimental studies on the blood pressure reducing effect of verapamil]. Dtsch Med Wochenschr (1970) 0.82
Penetration, permeation, and absorption of triamcinolone acetonide in normal and psoriatic skin. Arch Dermatol Res (1977) 0.81
[On the demonstration of biogenic amines in animal as well as in human skin and its tumors by thin layer chromatographic methods (according to Seiler). I. Alkylamines, colamine, piperidine, histamine, spermine and spermidine]. Arch Klin Exp Dermatol (1967) 0.81
Clotting in dialyzers due to low pH of dialysis fluid. Clin Nephrol (1977) 0.80
[On the determination of biogenic amines in the human skin and its tumors by thin layer chromatographic method (according to Seiler). II. Catecholamines (Dopamine, norepinephrine, epinephrine) and beta-phenylethylamine]. Arch Klin Exp Dermatol (1968) 0.80
Reflex heating of the skin and telethermography. Arch Dermatol Res (1982) 0.80
[Therapeutic value of antihistamines today. Dermatoses and allergic diseases of the mucous membranes]. Z Hautkr (1984) 0.79
Does a low protein diet really slow down the rate of progression of chronic renal failure? Blood Purif (1989) 0.79
Effects of riboflavin on Gunn rats under phototherapy. Pediatr Res (1979) 0.79
Haemodynamic effects of A-V shunts and their clinical significance. Proc Eur Dial Transplant Assoc (1972) 0.78
Historical perspectives of tretinoin. J Am Acad Dermatol (1986) 0.78
Practicability of the inulin plasma single-shot clearance. Contrib Nephrol (1990) 0.78
Melanin granula distribution and phagocytosis in psoriasis vulgaris after PUVA therapy. Arch Dermatol Res (1979) 0.78
Investigations on the binding sites of the basement membrane zone for pemphigoid antibodies in vitro. II. Immunohistochemical reactions of the reactive groups. Acta Derm Venereol (1977) 0.78
Polymer chain dynamics in a random environment: heterogeneous mobilities. Phys Rev Lett (2007) 0.78
Generalized Hailey-Hailey disease. Br J Dermatol (1978) 0.78
[Mechanism of mediators in human skin. Pharmacoanalysis and therapeutic aspects]. Hautarzt (1977) 0.78
Oral vitamin A acid in treatment of dermatoses with pathologic keratinization. Int J Dermatol (1977) 0.78
Oral vitamin A acid therapy. Acta Derm Venereol Suppl (Stockh) (1976) 0.78
NaCl injections in brain induce natriuresis and blood pressure responses sensitive to ANG II AT1 receptors. Am J Physiol (1995) 0.78
Limitations and problems of animal experiments in uremia. Contrib Nephrol (1988) 0.78
[Stimulation of autoantibody formation in pemphigoid due to proteolytic enzymes?]. Hautarzt (1976) 0.78
[Diagnosis and therapy of Helicobacter pylori infection. Guidelines of the German Society of Digestive and Metabolic Diseases]. Z Gastroenterol (1996) 0.77
The ultrastructure of mycobacterium marinum granuloma in man. Arch Dermatol Res (1978) 0.77
[Immunobiologic principles of allergic dermatoses]. Munch Med Wochenschr (1967) 0.77
Delayed progression of chronic renal failure: a prospective controlled trial with a low protein diet supplemented by keto acids. Contrib Nephrol (1985) 0.77
P. acnes and the chemistry of sebum. Acta Derm Venereol Suppl (Stockh) (1980) 0.77
Electron microscope findings after toxic doses of vitamin A acid in man. Acta Derm Venereol Suppl (Stockh) (1976) 0.77
Influence of the underlying renal disease on the rate of progression. Contrib Nephrol (1986) 0.77
Effect of islet transplantation on the glomerular changes in streptozotocin-diabetic rats. Virchows Arch A Pathol Anat Histol (1980) 0.76
Bioavailability, skin- and nailpenetration of topically applied antimycotics. Mykosen (1982) 0.76
Rate of deterioration of renal function in juvenile nephronophthisis. Pediatr Nephrol (1989) 0.76
Efficacy and side effects of erythropoietin used in the treatment of anemia of uremic rats. Contrib Nephrol (1988) 0.76
Protein excretion and renal adaptation of transgenic mRen2 rats to changing oral sodium loads. J Hypertens Suppl (1993) 0.76
[Results and consequences of long-term urea therapy for clinical practice]. Hautarzt (1992) 0.76
Vasoconstriction in response to corticosteroids observed in human lips. Dermatologica (1976) 0.76
Potential side-effects of erythropoietin. Lancet (1987) 0.76
[Permeation of labeled Oxiconazole. Comparison between the autoradiographic and horizontal slice technics with human skin]. Mykosen (1985) 0.76
Predictability of the progression of chronic renal failure. Kidney Int Suppl (1983) 0.75
Malignant nephrosclerosis in patients with hemolytic uremic syndrome (primary malignant nephrosclerosis). Curr Top Pathol (1977) 0.75
Determination of inulin clearance by using a single-sample method. Clin Nephrol (1993) 0.75
[Comparison of physical parameters of dermal blood circulation changes following epicutaneous application of benzylnicotinate. Thermal measurements, studies on the course of erythema, perspiration and skin resistance]. Arch Dermatol Forsch (1971) 0.75
[On the influence of exposure to dry heat on the parotis-secretion with special attention to conditions in atopic dermatitis]. Arch Klin Exp Dermatol (1968) 0.75
[Determination of biogenic amines in animal and human skin as well as tumors by a thin-layer chromatographic method (Seiler technic). 3. 5-Hydroxytryptamine (serotonin)]. Arch Klin Exp Dermatol (1969) 0.75
The influence of two different essential amino acid/keto analogue preparations on the clinical status of patients with chronic renal failure. Z Ernahrungswiss (1985) 0.75
[Hemorrhagic skin necrosis following vasoconstrictor catecholamines on the lower leg]. Arch Klin Exp Dermatol (1966) 0.75
The reaction of the normal and pathologically changed skin to tangential vibration effect of drugs on this reaction. Arch Dermatol Res (1978) 0.75
Minimum phototoxicity dose (MPD). Comparison of conventional light sources and different lasers. Arch Dermatol Res (1980) 0.75
[Autoradiographic studies on the distribution of tritiated atropine in human and animal skin]. Arch Klin Exp Dermatol (1969) 0.75
Dopamine effects on the microcirculation and veins of the skin after local application and their changes by antagonistic drugs. Arch Dermatol Res (1979) 0.75
[The mechanism of antigen-antibody reaction at the basement membrane zone in bullous pemphigoid. The question of interaction of complement factors and bivalent cations (author's transl)]. Arch Dermatol Res (1975) 0.75
Absorption of boric acid through human skin depending on the type of vehicle. Arch Dermatol Res (1982) 0.75
[Isomorphic structure of cantharidin-blisters in various bullous dermatoses]. Arch Klin Exp Dermatol (1970) 0.75
[Influencing the effect of epicutaneously applied trypsin by means of a trypsin inhibitor and dermatologic pretreatment of the human skin in vivo]. Arch Klin Exp Dermatol (1970) 0.75
[Terminal blood vessels of the skin in collagen diseases and generalized vasculitis]. Med Welt (1975) 0.75
[Blood flow and permeability of the terminal vascular bed in the skin]. Med Welt (1975) 0.75
[The diangostic value of skin tests with tissue-extracts, especially in lepra and sarcoidosis (author's transl)]. Immun Infekt (1975) 0.75
The effects of X-ray, ultraviolet and infrared irradiation on the basement membrane zone antibody reaction of the human skin in vitro. Acta Derm Venereol (1975) 0.75
[Exacerbation of bullous pemphigold through treatment with high-energy radiation (radiocobalt and betatron irradiation). 2 clinical cases)]. Z Hautkr (1975) 0.75
[Measles- - antibodies in psoriatic patients with and without methotrexate therapy]. Z Hautkr (1976) 0.75
[Physiologic bases for climate therapy in dermatology]. Arch Phys Ther (Leipz) (1968) 0.75
[The penetration of drugs into the skin]. Hautarzt (1975) 0.75
[Pharmaco-analytical studies on the blood circulation in human skin and mucosa]. Med Welt (1975) 0.75
[Hans Th. Schreus. September 10, 1892-January 27, 1970]. Dermatol Monatsschr (1970) 0.75
[Quantitative measurement of the histamine effect]. Dtsch Med Wochenschr (1970) 0.75
[Letter: Aurantiasis]. Hautarzt (1975) 0.75